Proliferation inhibition and differentiation induction of hepatic cancer stem cells by knockdown of BC047440: A potential therapeutic target of stem cell treatment for hepatocellular carcinoma

Oncology Reports

Volumn 31, Issue 4, 2014, Pages 1911-1920

  You, Nan ^a   Zheng, Lu ^a   Liu, Weihui ^b   Zhong, Xiao ^a   Wang, Weiwei ^a   Li, Jing ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b CHENGDU MILITARY GENERAL HOSPITAL   (China)

Author keywords

BC047440; Hepatic cancer stem cells; Hepatocellular carcinoma; Targeted therapy

Indexed keywords

HEPATOCYTE NUCLEAR FACTOR 4ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BC047440 GENE; CANCER STEM CELL; CARCINOGENICITY; CELL DIFFERENTIATION; CELL ISOLATION; CELL PROLIFERATION; CONTROLLED STUDY; GENE; GENE EXPRESSION; GENE FUNCTION; GENE SILENCING; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MITOSIS INHIBITION; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; RNA INTERFERENCE;

ANIMALS; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELL DIFFERENTIATION; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; FLOW CYTOMETRY; GENE KNOCKDOWN TECHNIQUES; LIVER NEOPLASMS; MICE; MICE, NUDE; NEOPLASM PROTEINS; NEOPLASTIC STEM CELLS; RATS; RATS, INBRED F344;

EID: 84908051991     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2014.3043     Document Type: Article

References (28)

1. Shiozawa Y, Nie B, Pienta KJ, Morgan TM and Taichman RS: Cancer stem cells and their role in metastasis. Pharmacol Ther 138: 285-293, 2013.
2. Cheng X and O'Neill HC: Oncogenesis and cancer stem cells: current opinions and future directions. J Cell Mol Med 13: 4377-4384, 2009.
3. Yamashita T and Wang XW: Cancer stem cells in the development of liver cancer. J Clin Invest 123: 1911-1918, 2013.
4. Padhya KT, Marrero JA and Singal AG: Recent advances in the treatment of hepatocellular carcinoma. Curr Opin Gastroenterol 29: 285-292, 2013.
5. Wilson GS, Hu Z, Duan W, et al: Efficacy of using cancer stem cell markers in isolating and characterizing liver cancer stem cells. Stem Cells Dev 22: 2655-2664, 2013.
6. Lee H, Kim JB, Park SY, Kim SS and Kim H: Combination effect of paclitaxel and hyaluronic acid on cancer stem-like side population cells. J Biomed Nanotechnol 9: 299-302, 2013.
7. Zheng L, Liang P, Li J, et al: ShRNA-targeted COMMD7 suppresses hepatocellular carcinoma growth. PLoS One 7: e45412, 2012.
8. Zheng L, Huang X, Liang P, et al: BC047440 overexpression is a risk factor for tumor invasion and poor prognosis in hepatocellular carcinoma. Hepatogastroenterology 57: 919-925, 2010.
9. Zheng L, Liang P, Zhou J, Huang X, Wen Y, Wang Z and Li J: BC047440 antisense eukaryotic expression vectors inhibited HepG2 cell proliferation and suppressed xenograft tumorigenicity. Braz J Med Biol Res 45: 97-103, 2012.
10. Liu WH, Li R and Dou KF: Convenient and efficient enrichment of the CD133+ liver cells from rat fetal liver cells as a source of liver stem/progenitor cells. Stem Cell Rev 7: 94-102, 2011.
11. Liu WH, Wang X, You N, et al: Efficient enrichment of hepatic cancer stem-like cells from a primary rat HCC model via a density gradient centrifugation-centered method. PLoS One 7: e35720, 2012.
12. Li CH, Wang YJ, Dong W, et al: Hepatic oval cell lines generate hepatocellular carcinoma following transfection with HBx gene and treatment with aflatoxin B1 in vivo. Cancer Lett 311: 1-10, 2011.
13. Chiba T, Kita K, Zheng YW, et al: Side population purified from hepatocellular carcinoma cells harbors cancer stem cell-like properties. Hepatology 44: 240-245, 2006.
14. Zhu Z, Hao X, Yan M, Yao M, Ge C, Gu J and Li J: Cancer stem/progenitor cells are highly enriched in CD133+CD44+ population in hepatocellular carcinoma. Int J Cancer 126: 2067-2078, 2010.
15. Espandiari P, Robertson LW, Srinivasan C and Glauert HP: Comparison of different initiation protocols in the resistant hepatocyte model. Toxicology 206: 373-381, 2005.
16. Yamashita T, Honda M, Nakamoto Y, et al: Discrete nature of EpCAM + and CD90+ cancer stem cells in human hepatocellular carcinoma. Hepatology 57: 1484-1497, 2013.
17. Malanchi I, Peinado H, Kassen D, et al: Cutaneous cancer stem cell maintenance is dependent on β-catenin signalling. Nature 452: 650-653, 2008.
18. Zhao C, Chen A, Jamieson CH, et al: Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia. Nature 458: 776-779, 2009.
19. Viale A, De Franco F, Orleth A, et al: Cell-cycle restriction limits DNA damage and maintains self-renewal of leukaemia stem cells. Nature 457: 51-56, 2009.
20. Cui H, Hu B, Li T, Ma J, Alam G, Gunning WT and Ding HF: Bmi-1 is essential for the tumorigenicity of neuroblastoma cells. Am J Pathol 170: 1370-1378, 2007.
21. Kim JH, Yoon SY, Kim CN, et al: The Bmi-1 oncoprotein is overexpressed in human colorectal cancer and correlates with the reduced p16INK4a/p14ARF proteins. Cancer Lett 203: 217-224, 2004.
22. Song K, Wu J and Jiang C: Dysregulation of signaling pathways and putative biomarkers in liver cancer stem cells (Review). Oncol Rep 29: 3-12, 2013.
23. Fan X, Matsui W, Khaki L, Stearns D, Chun J, Li YM and Eberhart CG: Notch pathway inhibition depletes stem-like cells and blocks engraftment in embryonal brain tumors. Cancer Res 66: 7445-7452, 2006.
24. Verma UN, Surabhi RM, Schmaltieg A, Becerra C and Gaynor RB: Small interfering RNAs directed against β-catenin inhibit the in vitro and in vivo growth of colon cancer cells. Clin Cancer Res 9: 1291-1300, 2003.
25. Piccirillo SG, Reynolds BA, Zanetti N, et al: Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells. Nature 444: 761-765, 2006.
26. DiDonato JA, Mercurio F and Karin M: NF-κB and the link between inflammation and cancer. Immunol Rev 246: 379-400, 2012.
27. Prud'homme GJ: Cancer stem cells and novel targets for antitumor strategies. Curr Pharm Des 18: 2838-2849, 2012.
28. Ning BF, Ding J, Yin C, et al: Hepatocyte nuclear factor 4α suppresses the development of hepatocellular carcinoma. Cancer Res 70: 7640-7651, 2010.